Latest Gilead Sciences Stories
BURLINGAME, Calif., Oct.
Provides use, cost forecast based on testing, future treatment rates ST. PAUL, Minn., Oct. 10, 2014 /PRNewswire/ -- Today's U.S.
BEERSE, Belgium, September 29, 2014 /PRNewswire/ -- CHMP also issues two label extensions for darunavir Janssen-Cilag International NV (Janssen)
GENEVA, September 25, 2014 /PRNewswire/ -- MPP signs sub-licences with six generic manufacturers for the development of Phase III
ReportsnReports.com offers Bronchopulmonary Dysplasia - Pipeline Review, H2 2014 and Respiratory Syncytial Virus (RSV) Infections - Pipeline Review, H2 2014 new market reports.
PITTSBURGH and HYDERABAD, India, Sept. 15, 2014 /PRNewswire/ -- Mylan Inc.
VIENNA, September 3, 2014 /PRNewswire/ -- New US Subsidiary to be located in the Philadelphia Area Nabriva Therapeutics AG, a biotechnology
- Large; stout; burly.